ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Callisto Pharmaceuticals,

Callisto Pharmaceuticals, (KAL)

0.00
0.00
(0.00%)
Cerrado 08 Diciembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KAL Últimas noticias

Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -

Callisto Pharmaceuticals, Inc. (AMEX: KAL), announced today that on April 7, 2008, it received notice from the American Stock Exchange indicating that AMEX intends to strike the...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals, Inc. Receives Notice From AMEX

NEW YORK, June 22 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (AMEX:KAL), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
UAMYUnited States Antimony Corp
US$ 1.895
(40.37%)
20.28M
GPUSHyperscale Data Inc
US$ 6.79
(36.35%)
647.91k
CHROChannel Therapeutics Corporation
US$ 0.8349
(26.31%)
1.09M
ROLRHigh Roller Technologies Inc
US$ 6.60
(16.40%)
29.63k
DSSDSS Inc
US$ 1.04
(12.95%)
93.24k
CTMCastellum Inc
US$ 0.28675
(-18.07%)
6.51M
PWPower REIT
US$ 1.90
(-16.30%)
1.06M
UMACUnusual Machines Inc
US$ 8.66
(-15.51%)
4.17M
UAVSAgEagle Aerial Systems Inc
US$ 5.735
(-14.40%)
1.82M
SCPXScorpius Holdings Inc
US$ 0.3978
(-13.75%)
515.71k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0.9556
(-4.11%)
614.58M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29.61
(1.68%)
49.15M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.165
(3.77%)
39.96M
SPYSPDR S&P 500
US$ 607.81
(0.19%)
30.8M
TZADirexion Daily Small Cap Bear 3X Share New
US$ 10.485
(-1.08%)
30.58M
Mr. Zen Mr. Zen 4 minutos hace
Northstar Gold Corp (CSE: NSG) has initiated diamond drilling at its wholly-owned Miller Copper-Gold Property near Kirkland Lake, Ontario. The company has partnered with Wiijiiwaagan Drilling Partnership to complete a 1,500 metre drill program by year-end. The drilling targets copper-gold-silver vol
NSGCF
capgain capgain 4 minutos hace
Here Comes The Sun (2019 Mix)

https://www.youtube.com/watch?v=GKdl-GCsNJ0
jxyzobrien jxyzobrien 6 minutos hace
White House billionaires boys club
Wants war on the poor by manipulating the media
America is waking up. FAFO
vuletini vuletini 7 minutos hace
Good golly Miss Molly
XRPUSD
lovethatgreen lovethatgreen 10 minutos hace
Parallel trials ? Rof dude

It states very clearly in the q human trials will be in se Asia prior to human trials in the usa .There is no mention of parallel trials.

The bedtime stories that are presented here ignoring what has been communicated directly from the compan
RDGL
prototype_101 prototype_101 11 minutos hace
TWST: Can you give some idea of how much advantage there is in terms of transmitting information versus using semiconductors?

Dr. Lebby: The incumbent technology today is semiconductors. These are materials like silicon, lithium niobate, or indium phosphide. These are all semiconducto
LWLG TWST
The Danish Dude The Danish Dude 15 minutos hace
And how long does it usually take to prove the efficacy of a glioblastoma treatment with OS endpoint?

SurVaxM started in 2013 and might still need a phase 3 trial.

From ASM this year

So we, we have some collaboration discussions underway, and at the appro
ASM NWBO
Mr. Zen Mr. Zen 16 minutos hace
AAH, Now I know why you did not make money in the market, you don't know how to read a 10-K

Leopard Energy (f/k/a Cyber Apps World Inc.) was incorporated on July 15, 2002, under the laws of the State of Nevada and engaged in a number of businesses until April 9, 2015, at which we merg
LEEN
Mdk1 Mdk1 17 minutos hace
New Paper out by ETH Zürich & Polariton Technologies: “ Plasmonic Modulators for Future High-Capacity Space Communication “
https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/709178/FiO_2024_PlasmonicsForSpace_sub2.pdf?sequence=1&isAllowed=y
https://www.research-col
LWLG
Maxthedog Maxthedog 20 minutos hace
Next gap on the downside will be .45.
ELTP
Konaploinks Konaploinks 24 minutos hace
IonQ has developed a significant patent portfolio that underscores its leadership in quantum computing technology. As of December 2024, the company holds over 600 issued and pending U.S. and international patents, which focus on innovations that enhance performance, scalability, and enterprise-grade
IONQ
knrorrel knrorrel 27 minutos hace
100 % i agree , the trend is clear to everyone - tomorrow it continues - $GVSI, too $FORW and .......

which favorites are there that will make the OTC hot again starting tomorrow ?
FORW GVSI
SunshineSmiles SunshineSmiles 30 minutos hace
Quite the potential indeed.

Current speed bump is Tynan dumping his 40 million shares at .02.

After that... BOOM!

[yt]-zwYU5Jf2X8?si=Yq-CM_BwNjN1xTMr[/yt]

IndexR
MONI
MONI
prototype_101 prototype_101 39 minutos hace
Lebby set out SAM/SOM guidance at the 2023 ASM, in 2024 coincident with the ONE AND ONLY TIMELINE he has used since at least as far back as the 2019 ASM, the Customer Acceptance was set for 2024 with SAM/SAM guidance for 2024 of 7900 modulators which would have been indicative of SAMPLING, heck that
ASM LWLG
JohnnyJay JohnnyJay 43 minutos hace
Dino,
Very glad to see someone else doing DD. I purchased my first D-wave on June 6th and have been slowly buying since that date. Consider these two components. The NQIA and Davidson Technologies. You can find info on my previous posts. Yes, federal contracts are forth coming. Another huge c
QBTS
TheSprinx TheSprinx 44 minutos hace
Here's a great thread to read.
Explains everything well. 👏🏼
https://x.com/wwtp_consultant/status/1865333541577310409?s=46&t=FWyCU7KfIDokGToTtqinIg

HMBL
TrendTrade2016 TrendTrade2016 45 minutos hace
you are late again...1.20 to 5.00
UPC
Zorch305 Zorch305 50 minutos hace
Good morning....Got RNVA?
RNVA
Nerd Beautiful Nerd Beautiful 50 minutos hace
Our big breakout is 12-18 months away! (And always will be) 🤣
LQMT
Papillionlover Papillionlover 51 minutos hace
Linked in says they are doing a crowdfunding?
ASPZ
manibiotech manibiotech 54 minutos hace
Proven in NWBO world means a decade
NWBO
SHEEPWOLF SHEEPWOLF 60 minutos hace
$ILLR: #Triller
THINK MARKET SHARE.
MARKET SHARE =REVENUE
Creators should be making the move to #Triller and taking advantage of its creator centric tools.
THINK MONETIZATION!
#TikTok

https://www.cnn.com/2024/12/07/tech/tiktok-ban-law-ruling-w
ILLR
mwab52 mwab52 1 hora hace
Time to wakie,wakie......🤑🤑........Go (RNVA & Team)
RNVA

Su Consulta Reciente

Delayed Upgrade Clock